New combo therapy takes on tough pancreatic cancer
NCT ID NCT07296341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called HRS-4642 combined with other cancer treatments for people with advanced pancreatic cancer that cannot be removed by surgery. About 60 adults aged 18 to 75 will take part. The goal is to see if the combination is safe and helps control the cancer longer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER WITH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100730, China